{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-000620","form_type":"8-K","ticker":"ACHC","cik":"0001520697","company_name":"Acadia Healthcare Company, Inc.","filed_at":"2023-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.222173+00:00","generated_at":"2026-06-16T12:44:11.877140+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Acadia Healthcare Q1 revenue up 14.2% to $704.3M; affirms FY 2023 guidance","bullets":["Revenue $704.3M (+14.2% YoY); same-facility revenue +13.3% on 6.5% more patient days and 6.4% higher revenue per day.","Net income $66.0M ($0.72 diluted EPS); adjusted income $68.7M ($0.75 diluted EPS).","Adjusted EBITDA $151.3M, +11.6% YoY; cash and revolver availability of $548.8M, net leverage 2.2x.","FY 2023 guidance affirmed: revenue $2.82-2.88B, Adj. EBITDA $635-675M, Adj. EPS $3.10-3.40.","Added 106 beds in Q1; plans to open 4 new inpatient facilities and at least 6 CTCs in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-000620","json":"https://secwatch.observer/filing/0001157523-23-000620.json","markdown":"https://secwatch.observer/filing/0001157523-23-000620.md","text":"https://secwatch.observer/filing/0001157523-23-000620.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323000620/0001157523-23-000620-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323000620/a53388404.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T12:44:11.877140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e75c69993ed1e362191af275b95c5c8dab77d5fd","claim":"Acadia Healthcare Company, Inc. reported the first quarter ended March 31, 2023 results: revenue $704.3 million, net income $66.0 million, EPS $0.72 per diluted share. Guidance reaffirmed.","evidence_excerpt":"The Company reported revenue of $704.3 million for the first quarter of 2023, compared with $616.7 million for the first quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323000620/0001157523-23-000620-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$704.3 million"},{"label":"Net income","value":"$66.0 million"},{"label":"EPS","value":"$0.72 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}